WJA
CLLS

Williams Jones & Associates’s Cellectis CLLS Stock Holding History

Williams Jones & Associates’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-12,650
Closed -$358K – 454
2018
Q2 		$358K Buy
12,650
+6,050
+92% +$180K 0.01% 329
2018
Q1 		$208K Buy
+6,600
New +$209K ﹤0.01% 406
2017
Q3 		– Sell
-9,450
Closed -$244K – 438
2017
Q2 		$244K Buy
+9,450
New +$226K 0.01% 363

Other funds holding CLLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Williams Jones & Associates's CLLS Position: Q3 2018 in Review

Williams Jones & Associates sold out of Cellectis (CLLS) in Q3 2018, closing a stake of 12,650 shares — an estimated $358K sold.

Williams Jones & Associates first reported a position in CLLS in Q2 2017 and held it in 3 quarters. The position peaked at $358K in Q2 2018. 81 funds tracked by Wall St. Rank hold CLLS as of Q3 2018.

  • Williams Jones & Associates reported no remaining Cellectis position as of Q3 2018 after selling out during the quarter.
  • Williams Jones & Associates sold 12,650 Cellectis shares in Q3 2018, an estimated $358K.
  • Williams Jones & Associates first reported a position in Cellectis in Q2 2017 and held it in 3 quarters.
  • Williams Jones & Associates's Cellectis position peaked at $358K in Q2 2018.
  • 81 funds tracked by Wall St. Rank held Cellectis as of Q3 2018.

Based on Williams Jones & Associates's 13F filing for Q3 2018, filed 14 Nov 2018.